Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 44 for:    TCR-T

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03925896
Recruitment Status : Recruiting
First Posted : April 24, 2019
Last Update Posted : September 12, 2019
Sponsor:
Information provided by (Responsible Party):
Hai-Qiang Mai,MD,PhD, Sun Yat-sen University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2020
Estimated Study Completion Date : August 1, 2022
Publications: